Overview

Gabapentin for the Treatment of Neuroleptic-Induced Tremor

Status:
Terminated
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
We will attempt to establish whether gabapentin as compared with placebo will reduce the severity of tremors caused by the use of antipsychotic medications. Baseline severity of tremor will be measured using both clinical ratings and ratings obtained with an instrument designed to measure tremor, giving more objective evidence of tremor frequency and severity.
Phase:
Phase 3
Details
Lead Sponsor:
Minneapolis Veterans Affairs Medical Center
Collaborator:
Pfizer
Treatments:
Antipsychotic Agents
Gabapentin
gamma-Aminobutyric Acid